| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf .... | 0 | 0 | 0 | 0 | 0 | 0 |
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | 0 | 0 | 0 | 0 | 0 | 0 |
| 4 | Total. Add lines 1 through 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | 0 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 0 | |||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 0 | 0 | 0 | 0 | 0 | 0 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 0 | 0 | 0 | 0 | 0 | 0 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 0 | 0 | 0 | 0 | 0 | 0 |
| 11 | Total support. Add lines 7 through 10 | 0 | |||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6 | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975 | ||||||
| c | Add lines 10a and 10b | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6Total annual distributions. Add lines 1 through 5. | 6 | |
|
7
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
7 | |
| 8 Distributable amount for 2025 from Section C, line 6 | 8 | |
| 9 Line 7 amount divided by Line 8 amount | 9 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2025 |
(iii) Distributable Amount for 2025 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2025 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2025 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2025: | ||||
| a From 2020....... | ||||
| b From 2021....... | ||||
| c From 2022....... | ||||
| d From 2023....... | ||||
| e From 2024....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2025 distributable amount | ||||
|
i
Carryover from 2020 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2025 from Section D, line 6: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2025 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2025, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2025. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2026. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2021..... | ||||
| b Excess from 2022..... | ||||
| c Excess from 2023..... | ||||
| d Excess from 2024..... | ||||
| e Excess from 2025..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|---|
| Part IV Section A General | See Schedule O Header - General for the Corporations voluntary-escalation rationale from Form 990-N to full Form 990 for TY2025 and for the Initial 5-Year Classification Period status disclosure relevant to Schedule A Part II Section C Line 13. |
| Software ID: | |
| Software Version: |
| Return Reference | Explanation |
|---|---|
| Part III, line 2 | During TY2025 the Corporation conducted the following program services. As the corporations prior tax filings filed under the prior name Utah Research Institute Inc. were Form 990-N e-Postcard returns for TY2022 TY2023 and TY2024 which do not include detailed program-service disclosure all five programs below are new disclosures relative to those prior filings. PROGRAM 1 - ANCHOR INCUBATOR DELIVERABLE: INVESTIGATIVE INTELLIGENCE EmberGraph Intel. First substantive deliverable of the Corporations incubator model. An investigative-intelligence program applying graph methods alternative data and forensic analysis to the structure of complex systems. TY2025 activity consisted of preparatory research methodology development and infrastructure setup; no separate financial activity through the corporate account during TY2025. The supporting Utah LLC entity EmberGraph Intel LLC EIN 41-4716159 was organized March 6 2026 as a subsequent event. PROGRAM 2 - POINT-OF-CARE MEDICAL DIAGNOSTIC UColIV POC Diagnostic. Continuing research program from the URI era. Targets a quantitative low-resource-setting diagnostic for urinary collagen type IV a marker of microvascular and kidney function relevant to chronic kidney disease and hypertension-associated nephropathy. URI submitted two competitive NIH applications for this program in 2023 R21 mechanism in June application ID GRANT13924257; SBIR mechanism in September same application number. Neither was funded. The TY2025 antibody procurement from Abcam Inc. 6,516.53 combined; settled by ACH on 4 29 2025 supported preparation of the Corporations preliminary clinical-validation manuscript reporting Spearman rho equal to 0.631 P equal to 9.5 times 10 to the negative 4 n=24 between urinary collagen type IV and estimated glomerular filtration rate in a clinical sample. The manuscript is in preparation for submission to Kidney International Reports. PROGRAM 3 - DEEP-TECH HARDWARE Mechatronics FPV Optics. Hardware development program continuing prior URI-era engineering workstreams mechatronic hand EMG signal acquisition; institutional research equipment including a Bambu Lab X1-Carbon Combo 3D printer procured 6 27 2024 for prototyping. Preparatory stages during TY2025; no additional material financial activity through the corporate account. PROGRAM 4 - FEDERAL COMPLIANCE INFRASTRUCTURE. Federal grant infrastructure registrations completed and continuously maintained throughout TY2025: SAM.gov UEI registration awarded 5 24 2023; FDA Establishment Registration 6 9 2024; NIH eRA Commons account 5 25 2024; Grants.gov registration 6 5 2023; DoD SBIR program registration 9 27 2024. These registrations position the Corporation for continued federal grant solicitation including future R21 SBIR and other competitive applications and require periodic recertification and account-status maintenance during the tax year. PROGRAM 5 - PUBLIC COMMUNICATIONS EDUCATIONAL OUTREACH. Public-facing institutional communications during TY2025 including operation of the corporate website pioneeringdeep.tech transitioned from utahresearchinstitute. org following the December 29 2025 legal name change board mission communications and external institutional positioning supporting donor cultivation federal grant solicitation and stakeholder communication. Individual officers may from time to time publish public-facing content in their personal capacities; such individual-officer communications are not corporate programs of the Corporation. |
| Part III, line 3 | During TY2025 the Corporation completed a planned governance reset and corresponding state-level filings: a September 24 2025 - In-person Articles of Amendment filed at the Utah Division of Corporations and Commercial Code Filing 250926578071B. Removed Elizaveta Iazykova and Nathan Kunz from the Director slate; recorded the corporations principal address change to 3709 East Blue Jay Lane Cottonwood Heights UT. b October 25 2025 - Articles of Amendment state filing 251025620831B. Added Director Nicholas C. Witham; reflected Director Benjamin Beacoms inactive status following his resignation. c December 29 2025 - Articles of Amendment legal name change state filing 251228728136B; filed January 2 2026; effective December 29 2025. Corporate name changed from Utah Research Institute Inc. to Pioneering Deep Tech Institute Inc. d Strategic repositioning. Adoption of the Updated Mission Statement December 28 2025 formalized the corporations operational model as a multi-product incubator accelerator. Original program lines UColIV POC diagnostic; mechatronic hardware continue. New program lines investigative intelligence anchor deliverable federal compliance infrastructure public communications were initiated or formalized during TY2025. No programs were discontinued during TY2025. |
| Part VI, Line 2 | The Corporation discloses one family relationship that existed during the tax year. Mr. Andrew M. Piskadlo Director throughout TY2025; Vice President Chief Research Officer through December 19 2025; President Treasurer from December 20 2025 onward and Ms. Elizaveta Iazykova Director President Chief Executive Officer and Treasurer from January 1 2025 until her removal by Board action effective in mid-2025 were married on July 14 2020 and legally separated on November 30 2023 since which date they have lived apart. Ms. Iazykova filed a divorce action in June 2025 which is currently pending. Mr. Piskadlo and Ms. Iazykova therefore had a continuing spousal relationship for IRS family-relationship purposes during the portion of TY2025 in which both served as officers and directors of the Corporation approximately January 1 through mid-2025. The Boards removal action against Ms. Iazykova was based on her business conduct on March 26 2025 at a Bench to Bedside pitch session at the Center for Medical Innovation at the University of Utah Health Sciences Center which conduct resulted in the Corporation being barred from CMI events. The precipitating business event predated the divorce filing by approximately three months. The Corporations subsequent renaming and the substitution of Director Nicholas C. Witham for the removed officer flow from the resulting trademark and domain disputes addressed separately at Part VI Section A Lines 4 and 5 and in the Reorganization Period 2025 narrative. The Corporations Board of Directors at incorporation March 11 2022 comprised five Directors: Andrew M. Piskadlo Elizaveta Iazykova originally seated under the name Elizaveta Piskadlo Galen Muske Benjamin Beacom and Michael P. Greenwald. Family-related Directors Piskadlo and Iazykova constituted two of five seats and have never constituted a majority of the Board at any time in the Corporations history. As of the date of this filing the Corporations three current Directors Piskadlo Witham Greenwald have no family relationships among them. No business relationships among the current officers or directors exist. |
| Part VI, Line 4 | The Corporations Articles of Incorporation were amended three times during TY2025: a September 24 2025 - Articles of Amendment filed in person at the Utah Division of Corporations and Commercial Code state filing 250926578071B removing Elizaveta Iazykova and Nathan Kunz from the Director slate of record and recording the corporations principal address change to 3709 East Blue Jay Lane Cottonwood Heights UT 84121. b October 25 2025 - Articles of Amendment state filing 251025620831B adding Nicholas C. Witham as Director and reflecting Director Benjamin Beacoms inactive status following his resignation. c December 29 2025 - Articles of Amendment legal name change state filing 251228728136B filed January 2 2026 effective December 29 2025. The corporate legal name changed from Utah Research Institute Inc. to Pioneering Deep Tech Institute Inc. The Corporations bylaws originally adopted March 11 2022 were not amended during TY2025; they remain in full force as adopted subject to forthcoming amendment to reflect the legal name change and refined officer structure. The bylaws refresh is committed to be filed with the State of Utah and notified to the IRS by end of calendar year 2026 per Section 4bi of the Combined Unanimous Written Consent of the Board of Directors of May 15 2026. |
| Part VI, Line 5 | The Corporation became aware during TY2025 of disputed claims by the removed officer Elizaveta Iazykova over corporate assets that the Corporation maintains were institutionally created and used: the corporate domain name registrations utahresearchinstitute. com utahresearchinstitute. org and utahresearchinstitute. net originally registered May 25 2022; the URI corporate logo and logo suite; the corporate Wix website hosting account; a USPTO trademark application Serial No. 99223857 filed by the removed officer on June 9 2025 for the corporate name Utah Research Institute as a personal mark; and U.S. Copyright registrations filed by the removed officer on June 11 2025 for the URI logo suite as personal works. The Corporation has preserved all institutional claims and intellectual property rights against the removed officer expressly memorialized in Section 4 of the Board Resolutions adopted December 20 2025. The Corporations response to the removed officers cease-and-desist communications is documented in the notarized response of July 8 2025 Version 6 executed by Andrew M. Piskadlo in Salt Lake City Utah as Vice President and Chief Research Officer. The Corporations strategic disposition of these disputed assets - including potential USPTO Notice of Opposition U.S. Copyright Office registration challenge UDRP WIPO domain-name proceedings GoDaddy Transfer Dispute and judicial proceedings in the U.S. District Court for the District of Utah - is preserved and under counsel review as of the date of this filing. No diversion of cash assets occurred; the disputed assets are intellectual property and domain registrations. The cumulative officer-loan balance disclosed on Schedule L Part II 20,200 owed to Mr. Piskadlo is a separate board-authorized standing reimbursable-advance practice unrelated to this diversion question. |
| Part VI, Line 8 | The Corporation did NOT contemporaneously document all governing-body meetings held during TY2025. This is disclosed honestly and addressed by retroactive reconstruction described below. During TY2025 the Corporations regular monthly board meeting cadence was disrupted by the executive-officer-removal proceeding and the related intellectual property dispute concerning the removed officer Iazykova. During this period the Corporation continued to conduct board business through working sessions held by remote communications equipment primarily Discord text and voice channels with notice agenda and the active participation of Directors constituting quorum. Decisions reached during these working sessions were treated as authorized board action and are reflected in the corporations operational record vendor agreements maintained federal registrations completed executive-officer-removal action effected cease-and-desist response transmitted mission-statement iteration completed name-change packet executed three state amendments in September October and December 2025. The Corporation acknowledges that formal contemporaneous written minutes were not produced for all such working sessions during this period. The Corporation has commenced a program of retroactive documentation. Two reconstructed-minutes documents have been adopted by the Combined Unanimous Written Consent of the Board of Directors dated May 15 2026 executed via DocuSign electronic signature pursuant to the Utah Uniform Electronic Transactions Act: a Reconstructed Minutes of the Special Meeting of the Board of Directors of June 11 2025; and b Reconstructed Minutes of the Organizational Meeting of the Board of Directors of January 10 2026. The Combined Consent and both Reconstructed Minutes documents together with nine supporting Exhibits are retained in the Corporations permanent governance records and are available to the IRS or to authorized public inquirers upon request. Beginning Saturday June 6 2026 the Board has resumed and committed to a regular monthly board meeting cadence with formal minutes prepared and signed by the Secretary within thirty 30 days of each meeting per Section 4a of the Combined Unanimous Written Consent of the Board of Directors of May 15 2026. |
| Part VI, Line 11a | This is the Corporations first full Form 990 filing. The Boards decision to voluntarily up-tier from Form 990-N filed for tax years 2022 2023 and 2024 under the prior name Utah Research Institute Inc. to the full Form 990 for TY2025 was made at the Special Meeting of the Board of Directors of December 20 2025 Cafe on 1st in connection with the corporate legal name change to Pioneering Deep Tech Institute Inc. and the strategic repositioning to a multi-product incubator and accelerator model. The decision and the associated review-process expectations were memorialized in the December 20 2025 board meeting resolutions and the accompanying NameChange Packet signed by all three current Directors. The Form 990 review protocol was further formalized in Section 5 of the Combined Unanimous Written Consent of the Board of Directors of May 15 2026 which provides: the President Chief Executive Officer Treasurer the Corporations e-filing officer prepares the return; the substantively complete final draft is circulated to the full Board for review immediately prior to transmission; Board concurrence on accuracy is recorded by the Secretary before submission via the Presidents Electronic Filing PIN through commercial Modernized e-File software Tax990 by SPAN Enterprises. The Combined Consent expressly authorizes transmission upon completion of this review process and does not require pre-transmission Director signatures because the e-file submission mechanism employs the Presidents PIN as the signing instrument. |
| Part VI, Line 19 | The Corporation makes its governing documents Articles of Incorporation as amended; bylaws as adopted March 11 2022; conflict-of-interest policy adopted March 22 2022 and continued in force under the PDTI name by Section 3 of the Combined Unanimous Written Consent of the Board of Directors of May 15 2026 Forms 1023 and 990 and financial statements available to the public upon request through the Presidents office at the Corporations principal address 3709 East Blue Jay Lane Cottonwood Heights UT 84121. Requests may be transmitted by mail to the principal address above or by email to the President at apiskadlo@pioneeringdeep.tech. Upon publication of the filed Form 990 by the Internal Revenue Service the return will also be available through the IRS Tax Exempt Organization Search TEOS database at apps.irs.gov app eos . |
| Part IX General | | Explanation:| FORM 990 PART IX FUNCTIONAL EXPENSES METHODOLOGY CASH BASIS The Corporations TY2025 Form 990 is prepared on the cash basis of accounting per Part XII Line 1. All expenses reported in Part IX reflect cash outflows occurring during calendar year 2025 including institutional expenses paid on behalf of the Corporation by the Vice President from personal accounts during the period of dispute-related access disruption treated as institutional expenses with corresponding officer-loan liability recognized under the standing reimbursable-advance authorization disclosed at Schedule L Part II. Line 14 Information technology of 1,488 is composed of: corporate-account Google Workspace 4 118.43 473.72; X subscription 7 11.82 82.71; Shopify recurring 87.84; plus off-corporate-account Google Workspace JanuaryAugust 2025 estimated 695.88 and GoDaddy domain renewal 5 30 2025 148.13 paid by the Vice President on personal accounts during the period of dispute-related access disruption. Off-account components 843.01 are reflected with corresponding officer-loan liability recognition on Schedule L Part II. Line 24a Research reagents and supplies of 7,355 is composed of: Abcam Inc. settlement on 4 29 2025 of 6,516.53 corporate-account ACH; relates to URI-era invoices for which payment posted in TY2025; plus Bio-Techne ELISA kit NBP2-75864 of 837.85 ordered 5 21 2025 by the Vice President on personal credit card on behalf of the Corporation reflected with corresponding officer-loan liability on Schedule L Part II. Both expenses support Program 2 UColIV POC Diagnostic. Internal transfers between the corporate Chase Business Complete Checking ending 1127 and the Vice Presidents personal accounts totaled 6,063.52 of outflows during TY2025. These transfers represent partial repayment of the cumulative officer-loan balance per the standing reimbursable-advance authorization and are NOT Part IX functional expenses; balance-sheet activity is disclosed under Schedule L Part II. |
| Part XI Line 8 | | Explanation:| Part XI Line 8 Prior period adjustments: 4,484. The Corporation transitioned for TY2025 from Form 990-N e-Postcard which does not require balance-sheet reporting to full Form 990 with complete Part X balance sheet. Two first-time balance-sheet recognitions are reflected on this return and are presented through Line 8 to maintain Part X Part XI mechanical reconciliation: a accrued payables to two former contractors Brian Clyde 1,500 and Owen Leishman 1,200 totaling 2,700 confirmed by direct claimant outreach on May 15 2026 pursuant to Section 6 of the December 20 2025 Board Resolutions; and b reconciliation of the cumulative officer-loan balance owed to Andrew M. Piskadlo of 1,784 above the previously-carried internal estimate identified during the URI-to-PDTI five-year bank-ledger reconstruction see Schedule L Part V methodology. No prior 990 filings require amendment because TY2022-TY2024 were Form 990-N submissions which do not include balance-sheet disclosure. |
| Header General | | Explanation:| Voluntary escalation from Form 990-N to full Form 990 for TY2025. Pioneering Deep Tech Institute Inc. formerly Utah Research Institute Inc. filed Form 990-N e-Postcard for tax years 2022 2023 and 2024 because gross receipts in each of those years were normally below the 50,000 990-N threshold. For TY2025 the Board of Directors elected voluntarily to file the full Form 990 above the 990-N tier the Corporation could have continued at for three reasons memorialized in the Special Meeting of the Board of December 20 2025 Cafe on 1st and the Combined Unanimous Written Consent of May 15 2026: a the Corporation completed a planned legal name change from Utah Research Institute Inc. to Pioneering Deep Tech Institute Inc. effective December 29 2025 Utah Articles of Amendment Filing # 251228728136B and elected to use the first return under the new legal name to clear the historical balance-sheet record including first-time recognition of the cumulative officer-loan balance owed to the President CEO Treasurer disclosed on Schedule L Part II and the accrued contractor payables disclosed on Part X Line 17; b the Corporation expanded its scope from a single-research-program posture to a multi-product incubator accelerator model serving the public benefit through targeted incubation of community-benefit deep-technology ventures scholarly research and publication and expert-led educational programming as formalized in the Updated Mission Statement adopted December 28 2025 Exhibit C DocuSign envelope 2F96071A-03D9-44C8-8F4B-FBD4729C01D9; and c the Corporation is preparing to enter substantive donor cultivation and federal grant solicitation in TY2026 for which a complete and transparent Form 990 public record advances institutional credibility with the foundation federal-agency and individual-donor communities the Corporation will solicit. Initial 5-year classification period status. The Corporation is in the fourth tax year of its initial five-year 170b1Avi classification period period effective 2 25 2022 per IRS Determination Letter DLN 26053565005442; concludes during TY2026. Per Schedule A Part II Section C Line 13 Lines 1418 are not computed for organizations in the initial 5-year period. The Corporations TY2026 fundraising plan ~2,000,000 target across Sorenson Legacy Foundation additional NIH SBIR competitive applications and individual donor cultivation is designed to populate Line 1 with substantial external contributions sufficient to satisfy the 33% public support standard when the five-year rolling computation first becomes operative in TY2027 the year following conclusion of the initial period. Cross-reference. Loan-classification methodology for all years 20212025 Line 1 zeros is the standing board-authorized reimbursable-advance practice adopted at the Organizational Meeting of March 11 2022 ratified at the Board Meeting of March 22 2022 and continued in force by Combined Unanimous Written Consent of the Board of Directors dated May 15 2026 Section 3. The cumulative officer-loan balance arising from this practice is disclosed on Schedule L Part II at 20,200 outstanding as of 12 31 2025 with full methodology in Schedule L Part V. |
| Part III Line 4 | | Explanation:| During calendar year 2024 the Corporation placed multiple research-reagent orders with Abcam Inc. Danaher subsidiary; corporation account 861736 in support of Program 2 UColIV POC Diagnostic. Abcams order-management system authorized the Corporations debit card at the time of each order but a downstream system defect prevented the actual card charges from posting on two invoices. The Corporation received the shipments and treated the corresponding cash as committed. Abcam re-issued the affected invoices for collection in April 2025; the Corporation settled both via ACH on April 29 2025 Invoice 3033464 1,854.83 Invoice 3162230 4,661.70 = combined 6,516.53. Settlement confirmation was received from the Abcam Credit Controller on May 5 2025. The 1 1 2025 corporate cash balance of 4,903.95 reconciles to the bank statement of record; the Abcam pre-commitment is reflected as a TY2025 Program 2 program-services expense. |
| Part VI Line 12 | | Explanation:| The Corporation operates under a standing board-authorized practice adopted at the Organizational Meeting of March 11 2022; ratified at the Board Meeting of March 22 2022; continued in force by Combined Unanimous Written Consent of the Board of Directors dated May 15 2026 Section 3 by which Officers and Directors may advance personal funds to pay corporate expenses with reimbursement when corporate funds are available. This practice has been the Corporations primary source of operating funds since formation in 2022. No interest accrues on these advances. Repayment is made as corporate cash flow permits; no fixed maturity. The 20,200 balance at 12 31 2025 Treasurers good-faith conservative estimate is composed of: a corporate Chase Business Complete Checking ending 1127 net officer-advance balance 11,573.66 computed from the five-year reconstruction of corporate-account flows; b Foundation Group SureStart Complete 501c3 formation engagement 3,800.00 initial 800 setup payment 1 21 2022 plus six monthly 500 installments through 8 1 2022 paid from personal joint Chase account ending 1880; c personal-account-paid institutional research equipment during 2024 3,124.44 Pipette. com 6 5 2024 724.48; AFG Bioscience 6 6 2024 805.00; Bambu Lab X1-Carbon 3D printer 6 27 2024 1,594.96; d Bio-Techne ELISA kit NBP2-75864 supporting Program 2 837.85 ordered 5 21 2025 on personal credit card; and e TY2025 off-corporate-account recurring web IT institutional expenses 844.01 GoDaddy 5 30 2025 148.13 Google Workspace JanAug 2025 estimated 695.88. Sum: 11,573.66 3,800.00 3,124.44 837.85 844.01 = 20,179.96 rounded to 20,200.00. Opening-balance reconciliation. The Corporations internal records carried an estimated balance of approximately 14,000 at 1 1 2025. The reconstruction completed in preparation for this Form 990 identified 1,784 of additional pre-2025 substantiation not previously incorporated into the internal estimate. This delta is reflected at Form 990 Part XI Line 8 Prior period adjustments to maintain Part X Part XI reconciliation accompanied by the explanation at Schedule O Part XI Line 8. Reserved amendments. The Corporation reserves the right to revise the 20,200 figure on a future return if a Abcam Invoice 3033466 771.93 currently treated as corporate-account-paid is subsequently confirmed to have been paid via the Presidents personal credit card; b pre-2025 personal-account recurring web IT expenses ~3,400 estimated are substantiated via Chase statement recovery; or c additional Foundation Group installment invoices beyond the 8 1 2022 termination date currently recorded are recovered. |
| Part VI Line 13 | | Explanation:| Whistleblower policy. The Corporation does not have a formally adopted written whistleblower policy as of 12 31 2025. A complete policy template is drafted and retained in the Corporations permanent governance records. Adoption is scheduled at the Boards first regular monthly meeting on June 6 2026 per Section 4biv of the Combined Unanimous Written Consent of May 15 2026. Possible acceleration via Unanimous Written Consent in late May 2026. |
| Part VI Line 14 | | Explanation:| Document retention and destruction policy. The Corporation does not have a formally adopted written document retention and destruction policy as of 12 31 2025. A complete policy template is drafted and retained in the Corporations permanent governance records. Adoption is scheduled at the Boards first regular monthly meeting on June 6 2026 per Section 4biii of the Combined Unanimous Written Consent of May 15 2026. Possible acceleration via Unanimous Written Consent in late May 2026. |
| Part VI Line 15 | | Explanation:| Compensation determination process. No compensation was paid to any officer director trustee key employee or independent contractor during TY2025. All three Directors served and continue to serve in volunteer capacity. A formal compensation-determination process incorporating the IRS rebuttable-presumption standard independent review comparability data contemporaneous substantiation will be adopted prior to compensating any officer or key employee in any future year. |
| Part VI General | | Explanation:| Forward-looking governance commitment. The Corporations Board has committed to adopting a complete governance pack including Conflict of Interest Reaffirmation and Annual Procedure Document Retention and Destruction Policy Whistleblower Policy Board Code of Ethics Gift Acceptance Policy Donor Privacy Policy Related-Party Transactions Policy Foreign Giving Policy Compensation Policy and Bylaws Restatement reflecting the legal name change across the June July August and September 2026 board meetings per Section 4b of the Combined Unanimous Written Consent of the Board of Directors of May 15 2026. All policy templates are drafted and held in the Corporations permanent governance records pending board adoption. |
| Part VII General | | Explanation:| The following persons served as Officers and or Directors of the Corporation at any point during TY2025. None received any reportable compensation other compensation or benefits. Andrew M. Piskadlo. Director full year; Vice President Chief Research Officer 1 1 2025 through 12 19 2025; President Treasurer 12 20 2025 forward interim term; formally elected President Chief Executive Officer Treasurer at the annual Organizational Meeting of January 10 2026 ratified by Combined Unanimous Written Consent of the Board of Directors of May 15 2026. Hours week: 60. Nicholas C. Witham. Director from October 25 2025 forward Articles of Amendment Filing # 251025620831B; Vice President from 12 20 2025 forward; Vice President Chief Technology Officer from January 10 2026 forward. Hours week: 5. Michael P. Greenwald. Director full year; Secretary from 12 20 2025 forward; continued as Secretary by the January 10 2026 Organizational Meeting. Hours week: 2. Elizaveta Iazykova also Elizaveta Piskadlo on certain state records. Director and President CEO Treasurer from 1 1 2025 until removal by Board action effective mid-2025 Notice of Executive Suspension transmitted 6 2 2025; formal removal at Special Meeting of 6 11 2025; state-record removal at Articles of Amendment of 9 24 2025. Nathan R. Kunz. Director from 1 1 2025 until resignation effective 5 14 2025; state-record removal at Articles of Amendment of 9 24 2025. Benjamin B. Beacom. Director and Secretary from 1 1 2025 until resignation accepted at Special Meeting of 10 24 2025; state-record reflection at Articles of Amendment of 10 25 2025. |
| Part VIII General | | Explanation:| All Part VIII lines are reported as 0 under the loan-classification basis. The Corporations primary source of operating funds since formation in 2022 has been standing board-authorized reimbursable advances from the President CEO Treasurer see Schedule L Part II and Schedule L Part V methodology which are properly classified as officer loans rather than contributions or program-service revenue. The Corporation received no external contributions grants program-service revenue investment income royalties rental income fundraising-event income gaming income inventory sales or other miscellaneous revenue during TY2025. |
| Part X General | | Explanation:| Opening-balance reconciliation note. The Corporations opening balance sheet at 1 1 2025 as carried on this return reflects internal records: cash of 4,903.95 corporate Chase Business Complete Checking ending 1127 and estimated officer-loan liability of approximately 14,000. The Corporation previously filed Form 990-N e-Postcard for tax years 2022 2023 and 2024; the 990-N form does not require balance-sheet reporting so the BOY balance sheet figures on this return are not derived from a prior Form 990 Part X. The cumulative officer-loan reconstruction completed in preparation for this return identified 1,784 of additional pre-2025 substantiation not previously incorporated into the internal 14,000 estimate; this delta is presented at Part XI Line 8 Prior period adjustments to maintain Part X Part XI mechanical reconciliation. Negative net assets explanation. Negative net assets of 22,891 at year-end 2025 reflects i the cumulative officer-loan balance owed to the President CEO Treasurer of 20,200 disclosed on Schedule L Part II; ii accrued payables of 2,700 to two former contractors confirmed by direct claimant outreach on 5 15 2026; offset by iii corporate cash of 9. Negative net assets in this context is not a financial-distress indicator; it is the consequence of first-time balance-sheet recognition by an organization previously filing Form 990-N. The Corporations TY2026 fundraising plan ~2,000,000 target across Sorenson Legacy Foundation additional NIH SBIR competitive applications and individual donor cultivation is designed to move the balance positive on receipt of the first material external contribution. |
| Part VII General | | Explanation:| Subsequent Events post-tax-year through filing date. a EmberGraph Intel LLC formation. Organized in Utah on March 6 2026 Utah Entity # 14669755-0160; EIN 41-4716159 assigned by the IRS the same date. Did not exist during TY2025; not on this return. Schedule R disposition will be evaluated for the TY2026 return. b First investigative brief issued by EmberGraph Intel in April 2026. c Annual Organizational Meeting January 10 2026 and Combined Unanimous Written Consent May 15 2026 Officer elections ratified; standing reimbursable-advance authorization continued in force; bylaws continued in force subject to forthcoming amendment to reflect the legal name change and refined officer structure; prior actions ratified; Reconstructed Minutes of the June 11 2025 Special Meeting and the January 10 2026 Organizational Meeting adopted. d Forward-looking governance commitments. Retroactive reconstructed-minutes program in progress; regular monthly board cadence resumes Saturday June 6 2026; governance pack adoption Whistleblower Policy Document Retention Policy Code of Ethics Compensation Policy Bylaws Restatement and related policies all drafted and held in the Corporations permanent governance records sequenced across June July August and September 2026 board meetings per the Combined Unanimous Written Consent of May 15 2026. e Principal address change. Reflected in the September 24 2025 Articles of Amendment. The Corporation is filing Form 8822-B Change of Address or Responsible Party Business concurrently with this return. f Bank account name update pending at JPMorgan Chase to reflect the new legal name contingent on receipt of the IRS Letter of Affirmation. g IRS Letter of Affirmation request. The Corporation has prepared a written request to IRS Tax Exempt and Government Entities EO Determinations P.O. Box 2508 Cincinnati OH 45201 for an updated Letter of Affirmation reflecting the legal name change with enclosures including the state-filed Articles of Amendment the December 20 2025 NameChange Packet the December 28 2025 Mission Statement Resolution and a copy of the original IRS Determination Letter DLN 26053565005442. |
| Part IX General | | Explanation:| FORM 990 PART IX FUNCTIONAL EXPENSES METHODOLOGY CASH BASIS. The Corporations TY2025 Form 990 is prepared on the cash basis of accounting per Part XII Line 1. All expenses reported in Part IX reflect cash outflows occurring during calendar year 2025 including institutional expenses paid on behalf of the Corporation by the then-Vice President from personal accounts during the period of dispute-related access disruption treated as institutional expenses with corresponding officer-loan liability recognized under the standing reimbursable-advance authorization disclosed at Schedule L Part II. Line 14 Information technology of 1,340 is composed of corporate-account Google Workspace 4 x 118.43 473.72; X subscription 7 x 11.82 82.71; Shopify recurring 87.84; plus off-corporate-account Google Workspace January-August 2025 estimated 695.88 paid by the then-Vice President on personal accounts during the period of dispute-related access disruption. Off-account components are reflected with corresponding officer-loan liability recognition on Schedule L Part II. Line 24a State filings of 35 comprises the Utah Business License renewal of 18 5 17 2025 and the Utah Consumer Protection charitable solicitation renewal of 17 9 24 2025. Line 24b Research reagents - Abcam settlement of 6,517 is the Abcam Inc. settlement of 6,516.53 on 4 29 2025 corporate-account ACH; URI-era Invoices 3033464 and 3162230 settled in TY2025. Supports Program 2 UColIV POC Diagnostic. Line 24c Bank fees of 233 comprises monthly service fees overdraft fees ACH initiation and card replacement on the corporate Chase Business Complete Checking ending 1127. Line 24d Off-account web hosting of 148 is the GoDaddy domain renewal of 5 30 2025 148.13 paid by the then-Vice President on personal account during the period of dispute-related access disruption. Reflected with corresponding officer-loan liability recognition on Schedule L Part II. Line 24e All other expenses of 1,038 comprises the Bio-Techne ELISA kit NBP2-75864 of 837.85 ordered 5 21 2025 by the then-Vice President on personal credit card on behalf of the Corporation supporting Program 2 Program services column 838; plus miscellaneous office supplies expenses of approximately 200 Management and General column. Internal transfers between the corporate Chase Business Complete Checking ending 1127 and the then-Vice Presidents personal accounts totaled 6,063.52 of outflows during TY2025. These transfers represent partial repayment of the cumulative officer-loan balance per the standing reimbursable-advance authorization and are NOT Part IX functional expenses; balance-sheet activity is disclosed under Schedule L Part II and Schedule L Part V. |
| Software ID: | |
| Software Version: |